Clinical trial
An Extension Study of Venetoclax in Subjects With Advanced Non-Hodgkin's Lymphoma
NCT01969695 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Extension Study of Venetoclax in Subjects With Advanced Non-Hodgkin's Lymphoma
- Lead sponsor
- AbbVie
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 20, 2013
- Completion date
- December 16, 2019
- Enrollment
- 11 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
non-hodgkin's lymphoma